Kavita Patel
CIK 1670683 · last filed 2026-04-28
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$320.1K
Companies
4
Total Filings
40
Lifetime Open-Market Net
-$8.34M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Arcellx, Inc. (ACLX) Delisted | Director | 0 | $115.07 | $0 | -$8.34M | 24 | 2026-04-28 |
| SLQT | Director | 363,214 | $0.88 | $320.1K | $0 | 7 | 2025-11-13 |
| Sigilon Therapeutics, Inc. (SGTX) Delisted | Director | — | $22.47 | — | $0 | 4 | 2023-08-11 |
| TESARO, Inc. (TSRO) Delisted | Director | 0 | — | — | $0 | 5 | 2019-01-22 |
Recent Filings · Page 3 of 4
40 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-08-01 | Arcellx, Inc. (ACLX) Delisted | Mixed | — | -$83.0K | EDGAR |
| 2024-07-11 | Arcellx, Inc. (ACLX) Delisted | Mixed | — | -$75.0K | EDGAR |
| 2024-06-28 | Arcellx, Inc. (ACLX) Delisted | Mixed | — | -$476.1K | EDGAR |
| 2024-06-06 | Arcellx, Inc. (ACLX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-11-16 | SLQT | Mixed | +203,125 | $0 | EDGAR |
| 2023-08-11 | Sigilon Therapeutics, Inc. (SGTX) Delisted | Disp (D) | — | $0 | EDGAR |
| 2023-06-16 | Arcellx, Inc. (ACLX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-05-22 | Sigilon Therapeutics, Inc. (SGTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-11-17 | SLQT | Mixed | +7,849 | $0 | EDGAR |
| 2022-05-27 | Sigilon Therapeutics, Inc. (SGTX) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.